INTERNATIONAL PATENT: I2O THERAPEUTICS, INC. FILES APPLICATION FOR "COMPOSITIONS COMPRISING PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF DUAL GLP-1/AMYLIN RECEPTOR AGONISTS AND USES THEREOF"

GENEVA, Dec. 31 -- I2O THERAPEUTICS, INC. (610 Main StreetCambridge, Massachusetts 02139) filed a patent application (PCT/US2025/034473) for "COMPOSITIONS COMPRISING PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF DUAL GLP-1/AMYLIN RECEPTOR AGONISTS AND USES THEREOF" on Jun 20, 2025. With publication no. WO/2025/264979, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GRAVES, Kurt (610 Main StreetCambridge, Massachusetts 02139), HENRY, Kevin (610 Main StreetCambridge, Massachusetts 02139)

Abstract: Provided her...